Bio-Techne (BSP:T1CH34) Accounts Payable & Accrued Expense : R$697 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Bio-Techne Accounts Payable & Accrued Expense?

Bio-Techne's quarterly accounts payable & accrued expense increased from Sep. 2024 (R$541 Mil) to Dec. 2024 (R$716 Mil) but then declined from Dec. 2024 (R$716 Mil) to Mar. 2025 (R$697 Mil).

Bio-Techne's annual accounts payable & accrued expense declined from Jun. 2022 (R$641 Mil) to Jun. 2023 (R$451 Mil) but then increased from Jun. 2023 (R$451 Mil) to Jun. 2024 (R$627 Mil).

Bio-Techne Accounts Payable & Accrued Expense Historical Data

The historical data trend for Bio-Techne's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Accounts Payable & Accrued Expense Chart

Bio-Techne Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

371.41

529.48

640.76

450.56

626.82

Bio-Techne Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															513.40	626.82	541.38	716.25	697.15

Bio-Techne Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Bio-Techne Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (BSP:T1CH34) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

TECH:USA TE1:Germany TE1:Germany

Address

614 McKinley Place N.E., Minneapolis, MN, USA, 55413

Website

https://www.bio-techne.com

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne Headlines

No Headlines